TGA Approval

NAGLAZYME galsulfase-rch 5mg/5mL concentrated solution for injection vial (125598)

ARTG ID

125598

ARTG Name

NAGLAZYME galsulfase-rch 5mg/5mL concentrated solution for injection vial

Sponsor

BioMarin Pharmaceutical Australia Pty Ltd

ARTG Date

March 20, 2007

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

BIOMARIN PHARMACEUTICAL AUSTRALIA PTY LTD

https://medical-cdn.nocode.com/drug_tga/408b4af69dc9b5a6d9cd46f0316a1296.pdf

https://medical-cdn.nocode.com/drug_tga/4a548e912ddaff26d094cb2c346e88f9.pdf

Ingredient Name

Galsulfase

Empowering clinical research with data-driven insights and AI-powered tools.

NAGLAZYME galsulfase-rch 5mg/5mL concentrated solution for injection vial (125598) - TGA 批准文号 | MedPath